CN100537524C - Preparation method of ioxaglic alcohol - Google Patents

Preparation method of ioxaglic alcohol Download PDF

Info

Publication number
CN100537524C
CN100537524C CNB200710038355XA CN200710038355A CN100537524C CN 100537524 C CN100537524 C CN 100537524C CN B200710038355X A CNB200710038355X A CN B200710038355XA CN 200710038355 A CN200710038355 A CN 200710038355A CN 100537524 C CN100537524 C CN 100537524C
Authority
CN
China
Prior art keywords
reaction
methyl
visipaque
group
general structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB200710038355XA
Other languages
Chinese (zh)
Other versions
CN101045698A (en
Inventor
史命锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Haizhou Pharmaceutical Co ltd
Original Assignee
SHANGHAI KUOIKEE LABORATORIES Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI KUOIKEE LABORATORIES Co Ltd filed Critical SHANGHAI KUOIKEE LABORATORIES Co Ltd
Priority to CNB200710038355XA priority Critical patent/CN100537524C/en
Publication of CN101045698A publication Critical patent/CN101045698A/en
Application granted granted Critical
Publication of CN100537524C publication Critical patent/CN100537524C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates a method that use dimeric 5 - azodermine - N, N - double ( 2, 3 - dioxy- propyl) - 2 and 4, 6 - triiodo meta xyylene diamine amide to prepare iodixanol. The characteristic is it takes reagent has following structure general expression (1) or (2) as dimeric reagent. After the dimeric step, generated iodixanol is extracted from hybrid for purification, and the rest not reactant raw material could be recovered. The iodixanol produced by this method not only be able to control and decrease subsidiary reaction effectively, advance reaction positive direction ongoing degree and greatly short reaction time, but also be able to recovery utilize not reactant raw material.

Description

A kind of preparation method of Visipaque 320
Technical field
The invention belongs to the chemicals field, specifically, relate to a kind of preparation method of Visipaque 320.
Background technology
(chemistry is by name: 1 for Visipaque 320, two (the acetamido)-N of 3-, N '-two [3,5-two (2,3-dihydroxypropyl aminocarbonyl)-2,4, the 6-triiodophenyl]-the 2-hydroxy propane) be a kind of phenyl triiodide lopps non-ionic type X-ray contrast medium, by the exploitation of Norway Nycomed company and in listing in 1993, commodity prestige by name is looked Parker (Visipaque), and it is just produced at present in a large number, some preparation methods are well-known, but these preparation methods' technological process all is that multistep is rapid, and therefore, it is very important coming these processes are optimized from the factor of aspects such as economy and environmental protection.
The preparation method of Visipaque 320 mainly contains three kinds (EP108638, WO0047549 and CN1340042), and they are all from the 5-nitroisophthalic acid:
The operational path that first kind of technological process (NO161358) for preparing Visipaque 320 adopts as shown in Figure 1, be by two polycondensation 5-acetamido-N at last, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine (calling " compd A " in the following text) obtains Visipaque 320.
Adopt this technological process to prepare Visipaque 320, in the report of document example, have only 18% yield, and need to make with extra care with preparative chromatography.In existing document (EP108638, WO0047549 and CN1340042), employing to be exactly with the compd A be raw material, and dimerization reagent is Epicholorohydrin.When repeating this test examples, we find because starting compound A fails complete dimerization is the product Visipaque 320, make yield low.Input raw material about 40% by reaction consumes after, the excessive alkylated reaction of target product begins more to preponderate than needed reaction, causes the Visipaque 320 content that needs in reaction mixture to descend.This is consistent with description in the document.Though document provides the method that reclaims compd A from reaction system, because transformation efficiency is low, generate the material complexity, be suitable for medicinal purity with still very difficult Visipaque 320 is purified to of traditional chemical purification method.Unique like this method that can obtain necessary purity Visipaque 320 is exactly a preparative liquid chromatography.Low yield adds expensive preparative chromatography purification process, just becomes the major defect of this method in industrial preparation Visipaque 320 flow process.
The operational path that second kind of technological process for preparing Visipaque 320 adopts as shown in Figure 2, this technological process comprises synthetic 5-amino-2,4, make its dichloride (WO9637459) behind the 6-triiodo m-phthalic acid (WO9637458), then the dichloride aminolysis is converted into compd A (US5705692, CN1228079 and WO9854124), last the same with first kind of preparation process, need carry out dimerization.So this method not only has the shortcoming same with first method, but also to adopt the chlorinating step that has corrosive thionyl chloride.
Priebe, Dugstad etc. (Acta Radiologica 36:21-31suppl.399,1995) have described the operational path of another kind of preparation Visipaque 320.Though it can avoid final step two polycondensation reaction of difficulty in above-mentioned 2 kinds of processes, but because this operational path is since 5-nitroisophthalic acid, need through the reaction of eight steps, reactions steps is long, and before and after synthetic, introduce the iodine atom in the order too early, and iodine is the most expensive reagent in this technical process.In addition, in this technological process, also need to adopt the chlorinating step that has corrosive thionyl chloride.
Summary of the invention
The present inventor finds under study for action, at existing two polycondensation 5-acetamido-N, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine prepares in the method for Visipaque 320, adopts to contain the halogenating agents such as dimerization reagent table chloropharin that following general structure (I) or reagent (II) substitute document, can control and reduce generation, the degree that the raising reaction forward is carried out of side reaction effectively and shorten the reaction times greatly.
Therefore, the objective of the invention is to overcome existing shortcoming and defect in the existing method for preparing Visipaque 320, thereby a kind of new method for preparing Visipaque 320 is provided.
Similar with the preparation method of existing Visipaque 320, the present invention is also by two polycondensation 5-acetamido-N, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine prepares Visipaque 320, and its main difference is that usefulness contains following general structure (I) or reagent (II) is used as dimerization reagent:
Wherein:
The R of general formula (I) is selected from: (1) is contained straight chain or substituted straight chain alkane group, the branched paraffin of C1 to C12 or is replaced the branched paraffin group; (2) contain the substituted aroma group that contains substituted radical on the aromatic group of C6 to C14 or the aromatic nucleus;
R1, the R2 of general formula (II) are selected from: (1) contains the straight or branched alkane group of C1 to C12; (2) contain the substituted aroma group that contains substituted radical on the aromatic group of C6 to C14 or the aromatic nucleus;
R3 be the H atom or Group, wherein R4 is fat alkane or the aromatic group that contains C1 to C6.
According to the present invention, R1 in the general formula (II) and R2 can be identical, also can be different.
According to the present invention, the R base in the described general structure (I) is: p-methylphenyl, dodecyl, m-nitro base or methyl.
According to the present invention, the R2 in the described general structure (II) is: methyl, p-methylphenyl, dodecyl, m-nitro base, propenyl, heptane base, 4-isopropyl naphthalene or 4-tert.-butylbenzene.
In a preferred embodiment of the invention, described two polycondensation reaction may further comprise the steps: with starting compound 5-acetamido-N, and N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine, alkali are dissolved in the reaction solvent, add dimerization reagent then, reacted 18-20 hours.
According to the present invention, described reaction solvent is a polar protic type solvent, (C1-C6) and their mixture also can be aprotic, polar type solvents, as dimethyl formamide (DMF), N,N-DIMETHYLACETAMIDE (DMA) and methyl-sulphoxide (DMSO) as water, low carbon chain fatty alcohol.
According to the present invention, after dimerization step finishes, use traditional chemical extraction method that the product Visipaque 320 is extracted from mixture, can obtain being suitable for the Visipaque 320 of pharmaceutical grade after being further purified.
In a preferred embodiment of the invention, after described dimerization reaction is finished, the pH value of reaction solution is transferred to nearly neutrality.
According to the present invention, the unreacted starting compound 5-acetamido-N of remainder behind the dimerization reaction, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine after further recycling, can be used for the dimerization step of a new round.
Adopt method provided by the invention to produce Visipaque 320, not only can control effectively and reduce side reaction generation, improve the degree that reaction forward carries out and shorten the reaction times greatly (foreshortening to about 20 hours) by original 46 hours, but also can further recycle unreacted starting compound 5-acetamido-N, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine, thus further reduce production costs.In the ability of on industrial production, strengthen producing in batches, make process compliance with environmental protection requirements more, operate easier.
Description of drawings
Fig. 1 is first kind of technological process for preparing the method for Visipaque 320 mentioning in the background technology.
Fig. 2 is second kind of technological process for preparing the method for Visipaque 320 mentioning in the background technology.
Fig. 3 is the HPLC figure that method of the present invention prepares the product concentration and the reaction times relation of Visipaque 320, and curve 1,2,3 is respectively the result who maps and obtained with the data of embodiment 6,12 and 17 among the figure.
Embodiment
Below in conjunction with specific embodiment, the invention will be further described.Should be understood that following examples only are used to the present invention is described but not are used to limit scope of the present invention.
Embodiment 1-8, Visipaque 320 preparation
Press shown in the table 1, get the 0.6mol solid sodium hydroxide, be dissolved in the 400ml solvent, be warming up to 45 ℃, add 0.501mol compound 5-acetamido-N, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine (to call " compd A " in the following text).
Behind all solids material dissolution, cool the temperature to below 15 ℃, add the dimerization reagent that 0.167mol contains general structure (I), be warming up to room temperature reaction in stirring reaction below 10 ℃ after 2 hours; Got one time sample in the reaction process every 2 hours, sample detects wherein Visipaque 320 content with the HPLC method, with the reaction times to Visipaque 320 content mapping (embodiment 6), the result is as shown in Figure 3.
As seen from Figure 3, react about 18-20 hours after, the content of Visipaque 320 no longer obviously increases in the reaction mixture, can determine that thus the reaction times is 18-20 hours.
Hydrochloric acid with 9% is neutralized to pH for nearly neutral (6-8) with reaction solution, and with termination reaction, then according to different reaction solvents, under 30-100 ℃ of outer baths, underpressure distillation removes and desolvates, and obtains white solid.In the gained white solid, add extraction agent (deionized water or low carbon chain fatty alcohol or their mixture), fully extract after-filtration; Filter cake is with an amount of dehydrated alcohol or washing with acetone, in 50 ℃ of reduced vacuum dry white solids, this white solid is the intact starting compound A of unreacted, can directly reclaim the dimerization reaction step that is used for next step; Filtrate then is further used for purifying and obtains highly purified Visipaque 320.
Table 1, Visipaque 320 preparation technology's reactive material and usage quantity thereof or reaction conditions
Embodiment Solvent The R base of general formula (I) (dimerization reagent) Extraction agent
1 Methyl alcohol Methyl Deionized water
2 Methyl cellosolve Propenyl Deionized water+methyl alcohol
3 Methyl alcohol The heptane base Methyl alcohol
4 Water Dodecyl Deionized water
5 Methyl alcohol The m-nitro base Ethylene glycol
6 Water P-methylphenyl Methoxyethanol
7 DMF 4-isopropyl naphthalene Diethylene glycol monomethyl ether
8 Methyl alcohol 4-tert.-butylbenzene Deionized water
Embodiment 9-20, Visipaque 320 preparation
Press shown in the table 1, get the 0.6mol solid sodium hydroxide, be dissolved in the 400ml solvent, be warming up to 45 ℃, add 0.501mol compd A (reclaiming raw material+fresh feed).
Behind all solids material dissolution, cool the temperature to below 10 ℃, add the dimerization reagent that 0.167mol contains general structure (II), be warming up to room temperature reaction in stirring reaction below 15 ℃ after 2 hours; Got one time sample in the reaction process every 2 hours, sample detects wherein Visipaque 320 content with the HPLC method, with the reaction times to Visipaque 320 content mapping (embodiment 12,17), the result is as shown in Figure 3.
As seen from Figure 3, react about 18-20 hours after, the content of Visipaque 320 no longer obviously increases in the reaction mixture, can determine that thus the reaction times is 18-20 hours, and is consistent with the result of embodiment 1-8.
Hydrochloric acid with 9% is neutralized to pH for nearly neutral (6-8) with reaction solution, and with termination reaction, then according to different reaction solvents, under 30-100 ℃ of outer baths, underpressure distillation removes and desolvates, and obtains white solid.In the gained white solid, add extraction agent (deionized water or low carbon chain fatty alcohol or their mixture), fully extract after-filtration; Filter cake is with an amount of dehydrated alcohol or washing with acetone, in 50 ℃ of reduced vacuum dry white solids, this white solid is the intact starting compound A of unreacted, can directly reclaim the dimerization reaction step that is used for next step; Filtrate then is further used for purifying and obtains highly purified Visipaque 320.
Table 2, Visipaque 320 preparation technology's reactive material and usage quantity thereof or reaction conditions
Embodiment Solvent R1 R2 R3(H/R4) * Extraction agent
9 Methyl alcohol Methyl Methyl H Water
10 Methyl alcohol Propenyl P-methylphenyl Methyl Methyl alcohol
11 Methyl alcohol The heptane base 4-tert.-butylbenzene H Methyl alcohol
12 Methyl alcohol Dodecyl The m-nitro base CH 3OCH 2 Ethylene glycol
13 Methyl cellosolve The m-nitro base Propenyl ClCH 2 Methyl cellosolve
14 Methyl cellosolve P-methylphenyl The heptane base Phenyl Water
15 Methyl cellosolve 4-isopropyl naphthalene 4-isopropyl naphthalene Methyl Methyl cellosolve
16 Methyl cellosolve Dodecyl Dodecyl Phenyl Diethylene glycol monomethyl ether
17 Water 4-tert.-butylbenzene Methyl ClCH 2 Methyl alcohol
18 Water Propenyl M-nitro CH 3OCH 2 Water
19 DMA The heptane base Methyl Methyl Methyl alcohol, alcohol mixture
20 DMSO 4-isopropyl naphthalene P-methylphenyl H Ethanol, water mixture
*: in the 5th row, except that independent H atom is the R3, other group is R4.
Result according to the foregoing description 1-20, adopt the technological process of production provided by the invention to produce Visipaque 320, not only can effectively control and reduce side reaction generation, improve degree that reaction forward carries out and shortened (foreshortened to about 20 hours by original 46 hours and finish) the long reaction times greatly, and further recycling of unreacted starting compound A, thereby further reduce production costs.In the ability of on industrial production, strengthen producing in batches, make process compliance with environmental protection requirements more, operate easier.

Claims (13)

1, a kind of preparation method of Visipaque 320 is by two polycondensation 5-acetamido-N, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine obtains Visipaque 320, it is characterized in that, with containing following general structure (I) or reagent (II) as dimerization reagent:
Figure C200710038355C00021
Wherein:
The R of general formula (I) is selected from: (1) contains the straight or branched alkane group of C1 to C12; (2) contain aromatic group or p-methylphenyl, m-nitro base, 4-isopropyl naphthalene or the 4-tert.-butylbenzene of C6 to C14;
R1, the R2 of general formula (II) are selected from: (1) contains the straight or branched alkane group of C1 to C12; (2) contain aromatic group or p-methylphenyl, m-nitro base, 4-isopropyl naphthalene or the 4-tert.-butylbenzene of C6 to C14;
R3 be the H atom or
Figure C200710038355C00022
Group, wherein R4 is fat alkane or the aromatic group that contains C1 to C6.
2, the method for claim 1 is characterized in that, the R base of the straight or branched alkane group that contains C1 to C12 in the general structure (I) is methyl, dodecyl or heptane base.
3, the method for claim 1 is characterized in that, the R1 of the straight or branched alkane group that contains C1 to C12 in the general structure (II) is methyl, dodecyl or heptane base.
4, the method for claim 1 is characterized in that, the R2 of the straight or branched alkane group that contains C1 to C12 in the general structure (II) is methyl, dodecyl or heptane base.
5, the method for claim 1 is characterized in that, described R4 is phenyl or methyl.
6, the method for claim 1 is characterized in that, R1 in the general structure (II) and R2 are identical or different group.
7, the method for claim 1 is characterized in that, described two polycondensation reaction may further comprise the steps: with former
Material compound 5-acetamido-N, N '-two (2, the 3-dihydroxypropyl)-2,4,6-triiodo isophthaloyl amine, alkali are dissolved in the reaction solvent, add dimerization reagent then, react 18-20 hours.
8, method as claimed in claim 7 is characterized in that, described reaction solvent is polar protic type solvent or aprotic, polar type solvent.
9, method as claimed in claim 8 is characterized in that, low carbon chain fatty alcohol that described polar protic type solvent is water, C1-C6 or their mixture.
10, method as claimed in claim 8 is characterized in that, described aprotic, polar type solvent is dimethyl formamide, N,N-DIMETHYLACETAMIDE or methyl-sulphoxide.
11, method as claimed in claim 7 is characterized in that, the pH value of the reaction solution after described dimerization reaction is finished transfers to nearly neutrality.
12, as each described method in the claim 1-11, it is characterized in that, also be included in after the dimerization reaction, reclaim unreacted starting compound 5-acetamido-N, N '-two (2, the 3-dihydroxypropyl)-2,4, the step of 6-triiodo isophthaloyl amine.
13, method as claimed in claim 12 is characterized in that, the recovery of described unreacted starting compound may further comprise the steps:
The pH value transfers to reaction solution after the nearly neutrality and removes by underpressure distillation and desolvate, the solid that obtains further adds extraction agent, fully extract after-filtration, reduced vacuum is dry after with dehydrated alcohol or washing with acetone obtains unreacted starting compound for filter cake, described extraction agent is water, low carbon chain fatty alcohol or their mixture, and described low carbon chain fatty alcohol is C1-C6 alcohol.
CNB200710038355XA 2007-03-23 2007-03-23 Preparation method of ioxaglic alcohol Active CN100537524C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200710038355XA CN100537524C (en) 2007-03-23 2007-03-23 Preparation method of ioxaglic alcohol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200710038355XA CN100537524C (en) 2007-03-23 2007-03-23 Preparation method of ioxaglic alcohol

Publications (2)

Publication Number Publication Date
CN101045698A CN101045698A (en) 2007-10-03
CN100537524C true CN100537524C (en) 2009-09-09

Family

ID=38770642

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200710038355XA Active CN100537524C (en) 2007-03-23 2007-03-23 Preparation method of ioxaglic alcohol

Country Status (1)

Country Link
CN (1) CN100537524C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754918B1 (en) * 2009-07-21 2010-07-13 Ge Healthcare As Crystallization of iodixanol in isopropanol and methanol
US7696381B1 (en) * 2009-07-21 2010-04-13 Ge Healthcare As Alternative dimerisation reagents for synthesis of iodixanol
US20110021832A1 (en) * 2009-07-21 2011-01-27 Ge Healthcare As Synthesis of iodixanol in water
US20110021825A1 (en) * 2009-07-21 2011-01-27 Ge Healthcare As Process for isolating iodixanol from an aqueous solution
US8969619B2 (en) * 2009-07-21 2015-03-03 Ge Healthcare As Synthesis of iodixanol in propyleneglycol

Also Published As

Publication number Publication date
CN101045698A (en) 2007-10-03

Similar Documents

Publication Publication Date Title
CN100537524C (en) Preparation method of ioxaglic alcohol
CN1178899C (en) Preparation of iodixanol
CN102725249B (en) Preparation and purification of iodixanol
CN1768044A (en) Process for manufacture of telmisartan
CN102964278B (en) Method for preparing CLT acid (2-amino-4-methyl-5-chlorobenzene sulfonic acid) by continuous catalytic hydrogenation reduction
CN108191669A (en) A kind of synthetic method of 1,2,4,5- tetraminos benzene and application
JP4546958B2 (en) Method for producing 4-aminodiphenylamine
CN108558679B (en) Synthetic method of Parylene A precursor
WO2023039940A1 (en) Method for preparing n,n,n-tripivaloyl-1,3,5-triaminobenzene
WO2023104063A1 (en) Preparation method for ioversol hydrolysate
AU717842B2 (en) Process for the preparation of contrast agents
CN106699594A (en) Preparation method of iopromide
CN1178908C (en) Method for preparing 2-nitro-5-(phenylthio)-anilines
CN101397293A (en) Green nitration method based on ion liquid catalysis
CN102060721A (en) Method for preparing L-2-aminobutyric acid by asymmetric conversion method
CN101417910B (en) Green nitration method of prazoles intermediate
CN107188804A (en) A kind of method that compound phosphotungstate catalyzes and synthesizes methyl oleate
CN1145064A (en) Process for producing carboxy arene sulphonic acids and their carboxylic acid derivatives
JP5790533B2 (en) Method for purifying phenylhydrazine-β-carboxylate compounds
CN101962339A (en) Be used for the acetylize of the diacetyl oxide of the volume that the use of synthetic non-ionic x-ray contrast agents reduces
CN104292109A (en) Method for preparing p-phenylenediamine
CN108191689A (en) A kind of energy-saving and environment-friendly continuous preparation method of novel Iohexol
CN112939796B (en) Synthetic method of 2,2 '-bis (trifluoromethyl) -4,4' -diaminobiphenyl
CN116102436A (en) New process for preparing serinol
CN109456219B (en) Method for stably and efficiently preparing N-acrylamide compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: SHANGHAI GUANJIE BIO-PHARM INTERMEDIATES CO., LTD.

Free format text: FORMER OWNER: SHI MINGFENG

Effective date: 20090410

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20090410

Address after: Room 303, Room 518, blue wave road, Zhangjiang, Shanghai, Pudong: 201203

Applicant after: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

Address before: Pudong Lijin 51 Shanghai Road, Lane 4, Room 302, post encoding: 200129

Applicant before: Shi Mingfeng

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: ZHEJIANG JIANFENG HAIZHOU PHARMACEUTICAL CO.,LTD.

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20100622

Address after: 201203 Room 518, No. 303 blue wave road, Zhangjiang, Shanghai, Pudong

Co-patentee after: ZHEJIANG JIANFENG HAIZHOU PHARMACY Co.,Ltd.

Patentee after: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

Address before: 201203 Room 518, No. 303 blue wave road, Zhangjiang, Shanghai, Pudong

Patentee before: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

C56 Change in the name or address of the patentee

Owner name: JIANFENG HAIZHOU PHARMACEUTICAL CO., LTD.;ZHEJIANG

Free format text: FORMER NAME: SHANGHAI KUOIKEE LABORATORIES CO., LTD.

CP03 Change of name, title or address

Address after: 317016 Zhejiang Coastal Industrial Park

Patentee after: ZHEJIANG JIANFENG HAIZHOU PHARMACY Co.,Ltd.

Patentee after: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

Address before: 201203 Room 518, No. 303 blue wave road, Zhangjiang, Shanghai, Pudong

Patentee before: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

Patentee before: ZHEJIANG JIANFENG HAIZHOU PHARMACY Co.,Ltd.

C56 Change in the name or address of the patentee

Owner name: ZHEJIANG HAIZHOU PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: JIANFENG HAIZHOU PHARMACEUTICAL CO., LTD.;ZHEJIANG PROVINCE

CP01 Change in the name or title of a patent holder

Address after: 317016 Zhejiang Coastal Industrial Park

Patentee after: ZHEJIANG HAIZHOU PHARMACEUTICAL CO.,LTD.

Patentee after: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

Address before: 317016 Zhejiang Coastal Industrial Park

Patentee before: ZHEJIANG JIANFENG HAIZHOU PHARMACY Co.,Ltd.

Patentee before: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20170119

Address after: 317016 Zhejiang Coastal Industrial Park

Patentee after: ZHEJIANG HAIZHOU PHARMACEUTICAL CO.,LTD.

Address before: 317016 Zhejiang Coastal Industrial Park

Patentee before: ZHEJIANG HAIZHOU PHARMACEUTICAL CO.,LTD.

Patentee before: SHANGHAI KUOIKEE LABORATORIES Co.,Ltd.

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 317016 coastal industrial zone, Linhai City, Zhejiang Province

Patentee after: Zhejiang Haizhou Pharmaceutical Co.,Ltd.

Address before: 317016 coastal industrial zone, Linhai City, Zhejiang Province

Patentee before: ZHEJIANG HAIZHOU PHARMACEUTICAL CO.,LTD.